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Chemical exposures are endemic to our modem industrial society. People who 
believe they are chemically sensitive are caught up in an acrimonious crossfire 
among competing roups of physicians including traditional allergists and clinical 
ecologists. This acrimony is fueled by different medical/scientific paradigms of the 
definition and nature of disease or symptoms associated with exposure to low levels 
of chemicals in food and water, the outdoor environment, the work environment, 
indoor air, and consumer p oducts. Much, but by no means all, of the early anecdotal 
evidence for chemical sensitivities has been reported by clinical ecologists-- 
physician practitioners whose clinical practices have come under intense criticism. 
However, chemical sensitivity is by no means the exclusive property of clinical 
ecology. The fields of occupational and environmental medicine increasingly 
contain sufficient examples to suggest hat a serious public health problem is 
emerging. Although a precise number for the magnitude of the problem is not 
available, evidence for significant and increasing chemical sensitivity isprovided by 
(1) recent dramatic increases in synthetic organic hemical production and pesticide 
use, (2) decreased ventilation i buildings, especially those that are "energy-tight," 
(3) increased outbreaks of sick-building illness, (4) increased reporting of symptoms 
in chemically contaminated communities, (5) increases in the numbers of physicians 
treating chemically sensitive patients, and (6) increases in the numbers of people 
reporting sensitivity. In this article we focus on the nature of chemical sensitivity. 
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The treatment of chemically sensitive patients i  a separate topic, beyond the scope 
of this article. 
Groups Sensitive to Low-Level Chemical Exposures 
A review of the literature on exposure to low levels of chemicals reveals four 
groups or clusters of people with heightened reactivity: (1) industrial workers, (:2) 
occupants of "tight buildings," including office workers and schoolchildren, (3) 
residents of communities whose air or water is contaminated by chemicals, and 
(4) individuals who have had personal and unique exposures to various chemicals 
in domestic indoor air, pesticides, drugs, and consumer products. These four 
groups are compared in Table 1. Note that they differ in professional and 
educational ttainment, age and sex, and the mix and levels of chemicals to which 
they are exposed, but that all have multiple symptoms involving multiple organ 
systems with marked variability in the type and degree of those systems. 
Symptoms are often "subjective." For example, central nervous ystem (CNS) 
symptoms uch as difficulty concentrating or irritability are common, and 
physical examinations are frequently unremarkable for individuals in each 
category. Careful analysis of these groups may reveal similarities and differences 
that can illuminate the origins and mechanisms ofchemical sensitivity. Recently, 
an additional cluster of possibly affected individuals has emerged--the r turning 
Gulf War veterans. 
Problems experienced by people in tight buildings, by industrial workers in a 
particular workplace, or by the residents of a contaminated community often 
develop within a relatively short time period--perhaps weeks or a few months. 
These problems may occur after a recognized event such as the installation of new 
carpeting, relocation to a new workplace, or changes in workplace or community 
exposures. The temporal cohesiveness between exposures and illness contributes 
to the recognition of the problem as real. The fact that individuals in such 
demographically divergent groups as those in Table l, including industrial 
workers, office workers, housewives, children, and most recently the Gulf War 
veterans report similar polysymptomatic complaints triggered by chemical 
exposures also suggests a real problem. In some chemically sensitive patients, no 
single, identifiable, "high-level" exposure seems to have been associated with 
the onset of their difficulties. Exposures may have occurred but were not 
recognized or remembered. Some observers suggest that repetitive or cumulative 
lower-level exposure vents may lead to the development of sensitivities. Still 
others implicate genetic predisposition, pregnancy, major surgery with anesthe- 
sia, pharmaceuticals, physical trauma, or major psychological stress as 
contributors to the illness. 
"l~pes of Sensitivity 
The different meanings of the term sensitivity are at least partially responsible 
for the confusion surrounding chemical sensitivity. Individuals differ in their 
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TABLE 1. Chemically Sensitive Groups 
Group Nature of Exposure Demographics 
Industrial workers 
Tight building occupants 
Contaminated 
communities 
Individuals 
Acute and chronic exposure to
industrial chemicals 
Off-gassing from construction 
materials, office equipment or
supplies; tobacco smoke; 
inadequate v ntilation 
Toxic waste sites, aerial pesticide 
spraying, round water 
contamination, air contamination 
by nearby industry and other 
community exposures 
Heterogeneous; indoor air 
(domestic), consumer p oducts, 
drugs, and pesticides 
Primarily males; blue collar; 20- 
to 65-years old. 
Females more than male; white- 
collar office workers and 
professionals; 20- to 65-years- 
old; schoolchildren 
All ages, male and female; 
children or infants may be 
affected first or most; pregnant 
women with possible ffects on 
fetuses; middle to lower class 
70-80% females; 50% 30- to 
50-years old; white, middle to 
upper middle class and 
professionals 
responses to increasing doses of a toxic substance. The underlying causes of 
inter-individual variability include age, sex, and genetic makeup; lifestyle and 
behavioral factors, including nutritional and dietary factors, alcohol, tobacco, 
and drug use; environmental factors; and preexisting disease (Ashford et al. 
1984). In the classical, toxicological use of the word sensitivity, those 
individuals who require relatively lower doses to induce a particular esponse 
are said to be more sensitive than those who would require relatively higher 
doses before experiencing the same response (Hattis et al. 1987). A hypothetical 
distribution of sensitivities, that is, the minimum doses necessary to cause 
individuals in a population to exhibit a harmful effect, is shown in curve A in 
Figure 1. (Plotting the cumulative number of individuals who exhibit a 
particular esponse as a function of dose generates a more familiar population 
dose-response curve, depicted as curve A in Figure 2.) This distribution 
describes the traditional toxicological concept of sensitivity. Curve A in Figure 
1 illustrates that health effects of  classical diseases are seen in a significant 
portion of the normal population at a certain dose; the sensitive and resilient 
populations are found in the tails of the distribution. (Of course, not all toxic 
substances have large variances or significant tails.) Painstaking scientific 
research and removing the effects of  confounding variables have resulted in the 
discovery of sensitive individuals at levels heretofore considered safe. Recent 
work on lead (Bellinger et al. 1987) and benzene (Rinsky et al. 1987) are just 
two examples. For the sensitive person, avoidance of low-level exposures 
generally leads to improvement, or at least to the arrest of the development of 
the disease. 
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FIGURE 1. Hypothetical distribution of different ypes of sensitivities as a function of 
dose. Curve A is a sensitivity distribution for classical toxicity, e.g., to lead or a solvent. 
Sensitive individuals are found in the left-hand tail of the distribution. Curve B is a 
sensitivity distribution of atopic or allergic individuals in the population who are sensitive 
to an allergen, e.g., ragweed or bee venom. Curve C is a sensitivity distribution for 
individuals with multiple chemical sensitivities who, because they are already sensitized, 
subsequently respond to particular incitants, e.g., formaldehyde orphenol. 
A second meaning of the word sensitivity appears in the context of classical 
IgE-mediated allergy (atopy). IgE is one of five classes of antibodies made by the 
body, and from the perspective of classically allergic individuals is the most 
important antibody. Atopic individuals have IgE directed against specific 
environmental incitants, such as ragweed pollen or bee venom. Positive skin tests 
in these individuals correlate generally with a rapid onset of symptoms when they 
are actually exposed to those allergens. The atopic individual exhibits a reaction, 
whereas non-allergic persons do not, even at the highest doses normally found in 
the environment. A hypothetical sensitivity distribution for an atopic effect is 
shown in curve B of Figure 1, and the dose-response curve derived from that 
distribution is found in curve B of Figure 2. Allergists include in the term allergy 
well-characterized immune responses that result from industrial exposure to 
certain chemicals, such as nickel or toluene diisocyanate (TDI). Most allergists 
refer to such responses as chemical sensitivity, but reserve this term for responses 
that have or appear to have a distinct immunological basis, preferring to use a 
term such as chemical intolerance for non-immunological responses to 
chemicals. 
Patients suffering from multiple chemical sensitivities (MCS) may be 
exhibiting a third and entirely different ype of sensitivity. Their health problems 
often (but not always) appear to involve a two-step process. The first step 
originates with some acute or traumatic exposure, after which the triggering of 
symptoms and observed sensitivities occur at very low levels of chemical 
exposure (the second step). The inducing chemical or substance may or may not 
be the same as the substances that thereafter provoke or "trigger" responses. 
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FIGURE 2. Hypothetical population dose-response curves for different effects. Curve A 
is a cumulative dose-response curve for classical toxicity, e.g., to lead or a solvent, curve 
B is a cumulative dose-response curve for atopic or allergic individuals in the population 
who are sensitive to an allergen, e.g., ragweed or bee venom, curve C is a cumulative 
dose-response curve for individuals with multiple chemical sensitivities who, because they 
are already sensitized, subsequently respond to particular incitants, e.g., formaldehyde or
phenol. 
(Sometimes the inducing substance is described as "sensitizing" the individual 
and the affected person is termed a "sensitized" person). The fact that normal 
persons do not experience even at higher levels of exposure those symptoms that 
chemically sensitive patients describe at much lower levels of exposure probably 
helps to explain the reluctance of some physicians to believe that the problems are 
physical in nature. To compound the problem of physician acceptance of this 
illness, multiple organ systems may be affected, and multiple substances may 
trigger the effects. Over time, sensitivities seem to spread, in terms of both the 
types of triggering substances and the systems affected (Randolph 1962). 
Avoidance of the offending substances is reported to be effective but much more 
difficult to achieve for these patients than for classically sensitive patients because 
symptoms may occur at extremely low doses and the exposures are ubiquitous. 
Adaptation to chronic low-level exposure with consequent "masking" of 
symptoms (discussed more fully later) may make it exceedingly difficult o discover 
these sensitivities and unravel the multifactoriai triggering of symptoms. A 
hypothetical sensitivity distribution for a single symptom for the already chemically 
sensitive person in response to a single substance trigger is shown in curve C of 
Figure 1, and the corresponding dose-response curve is shown in curve C of Figure 
2. It should be emphasized, however, that individuals who become chemically 
sensitive may have been exposed to an initial priming event that was toxic (e.g. 
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neurotoxic) as classically defined. Conceivably, exposure to certain substances, 
such as formaldehyde, might elicit all three types of sensitivities. 
A Working Definition for Multiple Chemical Sensitivity 
Given the multitude of environmental exposures (both chemical and food) that 
allegedly can result in a seemingly endless array of physical and mental 
syndromes and the frequent absence of findings on routine physical examination, 
the practitioner who sees these patients with their divergent and unfamiliar litany 
of complaints i  at great disadvantage in trying to diagnose the condition. 
Although there has been great pressure from the medical community to 
develop acase definition for MCS, no agreement on a definition has yet emerged. 
MCS is most likely a classification of diseases--such as infectious diseases-- 
which bear some similarities to one another but are not identical. Attempts to 
construct a single definition at this time might lead to the same kind of errors as 
lumping together, say, tuberculosis and viral pneumonia. To circumvent this 
problem, we propose the following operational definition of multiple chemical 
sensitivity, a definition that is based upon environmental testing: 
The patient with multiple chemical sensitivities can be discovered by removal from 
the suspected offending agents and by rechallenge, after an appropriate interval, 
under strictly controlled environmental conditions. Causality is inferred by the 
clearing of symptoms with removal from the offending environment and recurrence 
of symptoms with specific challenge. 
Isolation of the patient results in de-adaptation or unmasking (discussed later). 
Challenges conducted for research purposes hould be performed in a double-blind, 
placebo-controlled manner. In this way, the patient serves as his/her own control. 
This definition embodies the approach to discovering environmental causation that 
was developed by Randolph utilizing an environmental unit (a hospital unit as free 
as possible from chemical exposures). This operational definition is essential to 
resolving, once and for all, the debate about whether an allegedly chemically 
sensitive individual's ymptoms can or cannot be environmentally induced. For 
research purposes, a specially constructed environmental unit is necessary for 
scientific validation of the concept of chemical sensitivity. Ultimately, biological 
markers may be identified or a phenomenological definition may emerge that allows 
physicians to diagnose, at least tentatively, chemical sensitivity based on a history 
of a specific sensitizing event (such as a pesticide xposure) followed by evidence 
of chemical and food sensitivities, multisystem effects, improvement after 
avoidance of exposure, and similar experiences of persons with like histories. 
Adaptation 
One of the difficulties the observer encounters in trying to understand multiple 
chemical sensitivity is the ostensible lack of a central concept or unifying theory. 
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Such a unifying theory does exist and revolves around the concept of adaptation, 
known in other contexts as acclimation or acclimatization, habituation, 
developing tolerance, and even addiction. Understanding adaptation is important 
for two reasons: (1) adaptation makes difficult the subsequent discovery of the 
effects of a particular exposure on the body of an already sensitized person, and 
(2) chemical exposures may adversely impact adaptation mechanisms and thus 
lead to illness. Chemically sensitive persons seem to adapt and de-adapt 
differently than normal people. 
Adaptation has been recognized as occurring for a variety of substances, for 
example, ozone, nitroglycerin, and solvents. Solvents are among the chemicals 
most frequently implicated by chemically sensitive patients who attribute the 
onset of their illness to a particular exposure. Molhave and associates (Molhave 
et al. 1986) exposed individuals who had previously complained of sick building 
syndrome symptoms to a mixture of 22 volatile organic ompounds common in 
indoor air, predominantly solvents, for 2.75 hours. Levels were much lower than 
occupational health standards required and in the range of levels found in tight 
buildings. These healthy but sensitive subjects complained of nasal and throat 
irritation and inability to concentrate atlevels of solvents far below permissible 
occupational exposure levels. A similar study, using healthy subjects who had not 
previously complained of symptoms, showed no effect on the ability to 
concentrate (Otto et al. 1990). 
Chemically sensitive patients commonly report central nervous system 
symptoms at solvent levels as low as those used by Molhave and lower. Their 
complaints are consistent with the recognized health effects of these substances, 
albeit he levels of exposure that trigger symptoms in these patients may be lower 
by orders of magnitude. 
Adaptation is characterized by acclimatization (habituation, tolerance) with 
repeated exposures that result in a masking of symptoms. Withdrawal symptoms 
occur when exposure is discontinued. Once a person has adapted, further exposures 
have very little additional effect and therefore may not be observed, i.e., the effects 
of any additional exposure may not be observable because a kind of "saturation" 
effect has set in. Comprehensive environmental control, that is, an environmental 
unit, can overcome the masking effect of adaptation and the problems of 
overlapping exposures that result in overlapping responses to multiple agents. One 
of the main sources of confusion in diagnosing chemical sensitivity comes from 
failure of the examining physician to properly de-adapt the patient. 
Mechanisms of Multiple Chemical Sensitivities 
Any mechanism or model proposed for multiple chemical sensitivities should 
consider the following clinical observations associated with this illness: 
1. Symptoms involving virtually any system in the body or several systems 
simultaneously; 
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2. Differing symptoms and severity in different individuals, even those with 
the same exposure; 
3. Induction (that is, sensitization) by a wide range of environmental agents; 
4. Subsequent triggering by lower levels of exposure than those involved in 
initial induction of the illness; 
5. Concomitant food intolerances, estimated to occur in a sizable percentage of
those with chemical sensitivities; 
6. "Spreading" of sensitivity to other, often chemically dissimilar substances; 
different substances may trigger different constellations of symptoms; 
7. Adaptation or masking, that is, acclimatization to environmental incitants, 
both chemical and food, with continued exposure; loss of this tolerance with 
removal from the incitants; and augmented response with re-exposure after 
an appropriate interval (for example, 4 to 7 days); 
8. An apparent hreshold effect referred to by some practitioners as the 
patient's total load, a theoretical construct which suggests that illness 
occurs when the total load of biological, chemical, physical, and 
psychological stressors exceeds ome threshold for the patient. 
The most frequently cited theories to explain chemical sensitivity involve the 
nervous ystem, the immune system, or the interaction between them. These two 
systems most clearly link the external environment and the internal milieu (Bell 
1982). The rapid responsiveness of these systems also makes them attractive 
candidates because symptoms of food or chemical sensitivity have been reported 
to develop within seconds of exposure. 
Mechanisms Involving the Limbic System 
The olfactory nerves, with their receptors in the nose, link the external chemical 
environment tothe amygdala, hippocampus, and hypothalamus and other parts of 
the limbic system. The limbic system, or so-called "primitive smell brain," is a 
phylogenetically ancient part of the brain, present in all mammals. It governs the 
organism's interaction with its environment in many subtle ways essential for 
preservation f the individual and the species. The amygdala, popularly described 
as "emotion central," is involved in feelings and activities related to 
self-preservation, such as searching for food, feeding, fighting, and self- 
protection (MacLean 1986). Lesions in the septal area may cause hyperrespon- 
siveness to physical stimuli (such as touching, sounds, or temperature changes), 
hyperemotionality, loss of motivation, excessive sugar and water intake, and fear 
of unfamiliar situations (Isaacson 1982). The hippocampus is important for laying 
down new memories and thus is essential for learning (Gilman and Winans 1982). 
Memory and concentration difficulties are among the most disabling symptoms 
of patients with chemical sensitivities report. 
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In the hypothalamus, the immune, nervous, and endocrine systems converge. 
The hypothalamus governs (1) body temperature via vasoconstriction, shivering, 
vasodilation, sweating, and fever; (2) reproductive physiology and behavior; (3) 
feeding, drinking, digestive, and metabolic activities, and (4) physical manifesta- 
tions of emotion such as increased heart rate, elevated blood pressure, dry mouth, 
and gastrointestinal responses (Gilman and Winans 1982). The hypothalamus is 
also the locus at which the sympathetic and parasympathetic nervous system 
converge. Some symptoms of chemical sensitivity are suggestive of autonomic 
(sympathetic and parasympathetic) nervous system dysfunction, for example, 
altered smooth muscle tone producing Raynaud's phenomenon, diarrhea, 
constipation, and other symptoms. The hypothalamus appears to influence 
anaphylaxis and other aspects of immunity (Stein et al. 1981). Conversely, 
antigens may affect electrical activity in the hypothalamus (Besedovsky et al. 
1977). 
Lesions in the limbic region may be associated with irrational fears, feelings of 
strangeness or unreality, wishing to be alone and sadness (MacLean 1967). A 
feeling of being out of touch with or out of control of one's feelings and thoughts, 
not unlike that described by many patients with chemical sensitivity, may be 
perceived. 
The dynamic involvement of the hypothalamus and iimbic system in virtually 
every aspect of human physiology and behavior makes injury to these structures 
an intriguing hypothesis to explain chemical sensitivity's myriad manifestations. 
Sensitization or kindling of olfactory-limbic pathways by acute or chronic 
exposure to chemicals for chemical sensitivity such as solvents or pesticides (Bell 
et al. 1992) has been proposed as a putative mechanism. Subsequently, lesser 
exposures to chemicals might trigger inappropriate firing of nerve cells in the 
limbic area. Genetic endowment, prior environmental exposures, psychological 
stress, hormonal variations, and other factors may enhance neurological 
sensitization (Bell et al. 1992). 
Immunological Mechanisms 
Some view environmental illness as a disorder of immune regulation (Levin and 
Byers 1987). Relatively low-molecular-weight c emicals can alter native protein, 
by acting as haptens, and elicit an autoimmune-type response to the altered 
protein. Broughton and Thrasher (1988) report he development of antibodies to 
formaldehyde-albumin conjugates, evidence of immune system activation 
(activation marker Tal or T-lymphocytes), low titers of a variety of autoantibod- 
ies, and altered IL-I (interleukin) production in these individuals, suggestive of 
"subtle but chronic activation of the immune system" (Broughton 1990). They 
report hat exposed groups were three to four times more likely than controls to 
have one or more autoantibodies. Autoantibody titers were higher when exposure 
was ongoing and diminished after cessation of exposure. The clinical significance 
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of such antibodies in low titers is not known, but reported ifferences between 
exposed and unexposed groups are striking and warrant further investigation. 
Prospective studies of homogeneous exposed groups, for example, individuals 
exposed to the same sick building or chemical spill, and employing carefully 
matched control subjects, are needed to clarify the meaning and clinical utility, if 
any, of these markers. 
Biochemical Mechanisms 
Some physicians have noted vitamin and mineral abnormalities in their 
chemically sensitive patients (Johnson and Rea 1989; Rogers 1990). Conceiva- 
bly, individuals who have genetically or nutritionally defective enzyme 
detoxification systems might be more susceptible to low level chemical 
exposures. 
Levine and Reinhardt (1983) propose that environmental sensitivities may be 
the result of toxic chemicals reacting with cell constituents tocreate free radicals 
(which are formed when a molecule loses an electron). If an antioxidant molecule 
(such as Vitamin A, C, or E or selenium) is not present nearby to supply the 
missing electron, then an electron may be removed from an unsaturated lipid 
(lipid peroxidation) in a cell membrane damage, release of prostaglandins and 
other inflammatory mediators, and formation of antibodies to chemically altered 
tissue macromolecules. 
Rea et al. (1975) hypothesize that blood vessel constriction, inflammation, or
leakage in multiple organ systems may explain the bizarre combinations of 
symptoms in these patients. Symptoms might simply mirror the site and size of 
affected blood vessels. Smooth muscle constriction affecting blood vessels and 
the respiratory, gastrointestinal, nd genitourinary tracts is another plausible 
hypothesis. 
Possible Psychogenic Mechanisms 
Psychological symptoms are often reported by patients, but are not necessarily 
psychological in origin. Advances in biological psychiatry demonstrate hat 
genetic and biochemical factors contribute to central nervous ystem dysfunction 
and behavioral disturbance. Environmental exposures~ for example to solvents or 
pesticides, can have psychological sequelae. Symptoms of environmental 
chemical exposure may include depression, difficulty concentrating, anxiety, 
peculiar bodily sensations, headaches, and other subjective symptoms. Such 
symptoms may be interpreted by physicians and responses to psychosocial 
stresses, and patients may be willing to accept such insights lacking another 
explanation. Patients who have been worked up in an environmental unit often 
say they are amazed to find direct, cause-and-effect relationships between their 
symptoms and various foods and chemicals and find it difficult to accept 
psychological interpretations thereafter. 
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Many of the chemicals these patients ay cause their symptoms are solvents, 
pesticides, and other substances whose primary target organ, in terms of classical 
toxicity, is the brain. Interestingly, these individuals who "react" to levels well 
below those heretofore considered toxic most often complain of central nervous 
system symptoms. Thus, their complaints are in many respects consistent with 
known toxic actions of such substances, albeit the levels of exposure triggering 
their responses are much lower. 
That odor conditioning could occur in some cases is certainly possible. 
However, patients report reproducible symptoms to specific hemical exposures: 
(1) at levels below the odor threshold (Reaet al. 1975), (2) when their noses are 
clamped uring provocative testing, and (3) when anosmia (inability to detect 
odors) is present (Ziem 1989). These observations weigh heavily against classical 
conditioning as more than a partial explanation i certain patients. 
Some are of the opinion that multiple chemical sensitivity is an erroneous 
"belief system" that chemicals are the cause of their health problems 
(Staudenmayer and Selner 1987) and either advocate systematic deprogramming 
of the patients to purge them of their beliefs (Selner 1988), or believe that no 
psychotherapeutic intervention will help (Terr 1989). Others attribute multiple 
chemical sensitivities to atypical depression, hypochondriasis, post-traumatic 
stress disorder, hysteria, panic disorder, conversion disorder, or combinations of
these (Brodsky 1987; Schottenfeld 1987). 
Because psychological symptoms are not necessarily psychogenic n origin, 
future research should employ blinded, placebo-controlled chemical challenges in
order to distinguish between psychogenic and chemical etiologies. Such studies 
should be conducted in an environmental unit and must take adaptation i to 
account. 
Biomarkers for Chemical Sensitivity 
Acceptance of chemical sensitivity as a bona fide medical illness has been 
hampered by the lack of an identified biornarker for the condition. Other illnesses, 
such as fibromyalgia and chronic fatigue syndrome, share the same difficulty, but 
they do not have chemical sensitivity's double burden of organized, economically 
vested opposition and lack of a biomarker. Unfortunately, there is little incentive 
for pharmaceutical ompanies to support research that might identify abiomar-ker 
(which could be used as a gauge for drug treatment), given the fact that these 
patients generally avoid taking drugs. 
Up to now, most clinical studies of MCS patients have focused on markers of 
immunological, neurological, inflammatory, and psychological responses. Clini- 
cal ecologists, a few other physicians in the private sector and some commercial 
laboratories have reported alterations in a number of parameters in these patients, 
including T- and B-lymphocyte counts; helper/suppressor T-cell ratios; immu- 
noglobulin levels; autoimmune antibodies (including anti-nuclear, anti-smooth 
muscle, anti-thyroid, anti-parietal cell and other auto antibodies); activated 
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T-lymphocytes (Tal or CD-26); quantitative EEGs; evoked potentials; SPECT 
and other brain scans; levels of various vitamins, minerals, amino acids, and 
detoxification enzymes; and blood or tissue levels of pesticides, solvents, and 
other "pollutants." Flaws in these studies are many and varied including: failure 
to define the study population (no case definition used; failure to compare cases 
with age- and sex-definition used); failure to blind specimens; and failure to 
assess the accuracy and reproducibility of the test method. Studies performed by 
ecologists or commercial laboratories have been viewed with considerable 
skepticism by regulatory agencies and academic researchers. Some MCS 
proponents claim that different immunological bnormalities occur in different 
patients. However, if enough tests are done, statistically a certain umber will be 
abnormal (one in 20). This is not always taken into account. 
With regard to claims of immunological dysfunction, o consistently abnormal 
immunological parameter has been demonstrated in these patients to date. There 
are a number of reasons why a biomarker for chemical sensitivity may be elusive: 
1. If chemical sensitivity in fact involves alterations in brain or limbic 
function, then salient markers might not be accessible with current 
technology. For example, biochemical alterations in the central nervous 
system may not be reflected in blood chemistry determinations. Conceiva- 
bly, advances in functional brain imaging (including SPECT and PET) in 
the future may provide insight into blood flow or metabolic hanges that 
correlate with symptoms; 
2. Biomarkers of interest may be in normal ranges during normal non- 
exposure conditions. Provocative chemical challenges with pre- and 
post-exposure measurement of markers may be necessary to distinguish 
between patients and normal controls. Just as methacholine challenges are 
needed to diagnose certain patients with reactive airway disease, it may be 
necessary to perform low-level chemical challenges with these patients in 
order to elicit their symptoms and observe achange in a biomarker; and 
3. Patients may need to be de-adapted prior to challenge in order to see the 
most robust symptoms and changes in biomarkers. 
The fact that no consistently abnormal immunological marker has been found 
in these individuals to date does not necessarily mean that the immune system is 
unaffected. It is conceivable that chemically induced limbic/hypothalamic 
disturbances could alter immune function secondarily but in unpredictable 
directions. By analogy, if one were to throw a magnet into a computer, 
dysfunction o doubt would occur, but the direction and degree of dysfunction 
might vary depending upon where the magnet happened to land. Alternatively, 
specific immune cell subsets or immunocytokines not yet explored in these 
patients may prove significant in the future. To date, only one provocative 
challenge test has been performed on chemically sensitive patients (Doty et al. 
1988). In this study, patients manifested ecreased nasal patency relative to 
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controls, both before and after challenge. Similar low-level exposure provocative 
challenge studies that examine other parameters of interest are needed. 
Advancing the Understanding of Chemical Sensitivity 
While much posturing by medical societies has produced one-sided published 
opinion on chemical sensitivity, two recent conferences are noteworthy for their 
efforts to bring together scientists and physicians of divergent views to discuss 
needed research and future initiatives. The National Academy of Sciences Board 
on Environmental Studies & Toxicology held a multidisciplinary workshop in 
1991 sponsored by the EPA Office of Indoor Air (NRC 1992). The Association 
of Occupational & Environment Clinics also held a workshop in 1991 sponsored 
by the Agency for Toxic Substances and Disease Registry (ATSDR) involving 
primarily occupational and environmental physicians (AOEC 1992). Both 
conferences lead to published proceedings which contain a wide range of views 
and discussions that provide a balanced perspective on chemical sensitivity. 
Consensus was reached in both meetings concerning the need for and direction 
of further research. Specific research recommendations included: (1) the 
identification of sensitizing agents responsible for the initiating event, (2) the 
performance of blinded chemical challenges of those [sensitive] persons already 
sensitized in a controlled environment, and (3) the undertaking of prospective 
studies of groups of recently exposed individuals uch as those working in a 
recently renovated building. Challenge studies and prospective exposure-driven 
(event-driven) studies focusing on the most sensitive individuals in the 
population are imperative for comprehensive human risk assessment and 
responsive nvironmental policy. Both conferences attempted to arrive at initial 
case definitions for research purposes, but the definitions were not identical. 
Remembering that MCS is unlikely to be a single disease, efforts to construct a 
case definition, especially one that defines away symptoms that have other 
disease labels such as reactive airways disease (RADS), allergic rhinitis, or 
chronic fatigue syndrome, are likely to obfuscate and delay rather than hasten 
clarification of the nature of MCS. 
Public Policy Implications 
The previous discussion has focused on the description of, and scientific issues 
attending, the problems of chemical sensitivity. Although the precise nature of 
this condition (or conditions) and the underlying mechanisms remain somewhat 
uncertain and are evolving in nature, chemical sensitivity seems sufficiently 
well-recognized to require attention by government, industry, and the medical 
profession. Actions are needed for establishment of regulations minimizing 
exposures to certain chemicals, notification of sensitive or potentially sensitive 
populations to past or possible future exposures, accommodations i  housing and 
employment, and compensation for damage to health. The strength of the 
evidence sufficient o trigger a particular regulatory, legal, or political response 
464 NICHOLAS A. ASHFORD AND CLAUDIA S. MILLER 
may differ according to the area of action--i.e., notification, control of exposures, 
accommodation r compensation--what is called the "burden of persuasion" in 
legal terms. 
Public policy needs to be focused toward two distinct groups: (1) those 
individuals who could become sensitized as a result of an initiating exposure, and 
(2) those individuals who have already become sensitized and are now sensitive 
to chemicals at extremely low levels. Regulations and policies need to be 
developed to prevent sensitization of individuals in the first place. Sensitizing 
events occur in domestic indoor or white-collar work environments (possibly by 
exposure to certain pesticides). Other sensitizing events occur in industrial 
workplaces (possibly by classical sensitizers such as toluene diisocyanate or by 
solvents), in contaminated communities, and as a result of exposure to consumer 
products, pharmaceuticals, or possibly anesthesia. To prevent sensitization we 
would need to identify possible sensitizers and establish regulatory standards 
within the appropriate r gulatory regime. If, in fact, chemical sensitivity proceeds 
through a neurotoxic mechanism, attention should be focused on the neurotoxic- 
ity of chemicals and the development of appropriate standards. To the extent hat 
immunotoxic mechanisms are at play, attention should be directed toward 
immunotoxicity. The indoor air environment presents a particularly difficult 
regulatory challenge because no single regulatory regime applies, even though 
the Environmental Protection Agency has established an Office of Indoor Air in 
its Office of Air and Radiation. Regulation of consumer products, building 
materials, and construction practices, as well as pesticide applications, are but a 
few of the areas that would need to receive attention. 
In addition to establishing regulations minimizing exposures to sensitizing and 
triggering chemicals, advance notification of possible sensitizing or triggering 
exposures hould also be considered. In Massachusetts, for example, advance 
notice of pesticide applications in both public buildings and apartment buildings 
is now required. For individuals who are already sensitized, public policy must 
focus on ways to accommodate them by providing chemically less contaminated 
work environments, schools, and housing. Indeed the recently passed Americans 
with Disabilities Act requires "reasonable accommodation" for those individuals 
who are in fact or are considered isabled. This means that although "proof" that 
a particular person has chemical sensitivity is absent, discrimination by 
employers, landlords etc. may be illegal if the person is regarded as disabled by 
the discriminator. This feature of the law gets around the need for the person who 
is the target of discrimination from proving that he/she has chemical sensitivity or 
that it, in fact, exists as a medical condition. 
For a particular individual, this accommodation will probably need to he 
temporary in nature, except for those who are severely afflicted. Accommodation 
can take the form of providing aworkplace with adequate ventilation, removal of 
offending substances, location in a temporary office, allowing the person to work 
at home, the cessation of pesticide application at certain times, changes in 
CHEMICAL SENSITIVITY 465 
cleaning materials, etc. Regulatory and corporate policies are needed to 
accommodate hese individuals in an immediate, humane, and understanding 
manner. 
At first, addressing the needs of people who are exquisitely sensitive to 
chemicals at possibly several orders of magnitude lower than the conventional 
toxic limits might seem to present an impractical and insurmountable challenge. 
However, if an aggressive set of initiatives to prevent future sensitization were 
instituted, then we might eliminate the next generation of sensitive individuals, 
and the need to accommodate or compensate hem would become much less 
burdensome in practice. 
For persons whose health is already damaged, compensation can come from 
the workers' compensation, tort (court-awarded damages), social security, or 
private insurance disability systems. Under workers' compensation, the worker 
must prove that the injury was job-related by a preponderance of the evidence, 
i.e., that his/her condition was more likely than not caused by (or exacerbated by) 
a workplace xposure. The same burden is required in a tort suit for damages in 
the courts against a product manufacturer, pesticide applicator, owner of a 
building, etc. The recent Daubert (Daubert 1993) decision in the U.S. Supreme 
Court, expanding the admissibility of scientific evidence in the courts, is likely to 
make it easier for plaintiffs to present evidence of the developing science behind 
chemical sensitivity in order to seek damages. The burden in social security 
disability awards is less than it is in workers' compensation r the tort system, and 
the burden for private insurance varies with the insurance policy. 
In sum, chemical sensitivity is a debilitating condition and a serious public 
health concern, but one that can be addressed by aggressive, coordinated public 
and private sector efforts. Understanding the nature of this difficult, if not 
bewildering, condition is the first step. 
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